ATRC Stock Analysis: Buy, Sell, or Hold?
ATRC - AtriCure, Inc.
$31.79
2.06 (6.93%)
▲
5d:
+13.01%
30d:
+22.93%
90d:
+12.29%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ATRC is 8.6% above its trading range ($29.26). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ATRC is 8.6% above its trading range ($29.26). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.98
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $31.79, which is considered extended relative to its 30-day fair value range of $26.84 to $29.26. From a valuation perspective, the stock is trading at a premium (Forward PE: 91.2) compared to its historical average (82.3). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ATRC is in a downtrend. The price is approaching resistance at $31.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.9% recently.
Market Sentiment: ATRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.00 (+47.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATRC is in a downtrend. The price is approaching resistance at $31.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.9% recently.
Market Sentiment: ATRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.00 (+47.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$26.84 -
$29.26
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range (+8.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.9%)
- BULLISH: Trading 47.8% below Wall St target ($47.00)
- NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
- CAUTION: Extended 8.6% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$26.84 -
$29.26
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$27.24
Resistance Level
$31.82
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
91.17
Wall Street Target
$47.00
(+47.8%)
Revenue Growth (YoY)
14.3%
Profit Margin
-0.8%
Valuation Premium vs History
+3.5% premium
PE vs Historical
91.2 vs 82.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$32.90
(+4%)
2-Year Target
$34.05
(+7%)
3-Year Target
$35.25
(+11%)
3-Yr Target (if PE normalizes)
(PE: 91→82)
PE COMPRESSION
$31.82
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 91.2, Growth: 186.1%)
$107.29
(+238%)
Base:
(SPY PE: 21.8, Growth: 186.1%)
$25.63
(-19%)
Bear:
(PE: 18.5, Growth: 186.1%)
$21.79
(-32%)
Share & Embed Analysis
Last updated: July 04, 2026 12:49 PM ET
Data refreshes hourly during market hours. Next update: 1:49 PM
Data refreshes hourly during market hours. Next update: 1:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Vinayak Doraiswamy
SELL
5000 shares
2026-03-12
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
